Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis

por Thomas, Divya, Radhakrishnan, Prakash
Publicado 2019

Role of Tumor and Stroma-Derived IGF/IGFBPs in Pancreatic Cancer

por Thomas, Divya, Radhakrishnan, Prakash
Publicado 2020

The (Sialyl) Tn antigen: Contributions to immunosuppression in gastrointestinal cancers

por Rajesh, Christabelle, Radhakrishnan, Prakash
Publicado 2023

Truncated O‐glycans promote epithelial‐to‐mesenchymal transition and stemness properties of pancreatic cancer cells

por Thomas, Divya, Sagar, Satish, Caffrey, Thomas, Grandgenett, Paul M., Radhakrishnan, Prakash
Publicado 2019

MicroRNA-200c Modulates the Expression of MUC4 and MUC16 by Directly Targeting Their Coding Sequences in Human Pancreatic Cancer

por Radhakrishnan, Prakash, Mohr, Ashley M., Grandgenett, Paul M., Steele, Maria M., Batra, Surinder K., Hollingsworth, Michael A.
Publicado 2013

Role of keratan sulfate expression in human pancreatic cancer malignancy

por Leiphrakpam, Premila D., Patil, Prathamesh P., Remmers, Neeley, Swanson, Benjamin, Grandgenett, Paul M., Qiu, Fang, Yu, Fang, Radhakrishnan, Prakash
Publicado 2019

MUC1 Regulates Expression of Multiple microRNAs Involved in Pancreatic Tumor Progression, Including the miR-200c/141 Cluster

por Mohr, Ashley M., Bailey, Jennifer M., Lewallen, Michelle E., Liu, Xiang, Radhakrishnan, Prakash, Yu, Fang, Tapprich, William, Hollingsworth, Michael A.
Publicado 2013

Truncated O-Glycan-Bearing MUC16 Enhances Pancreatic Cancer Cells Aggressiveness via α4β1 Integrin Complexes and FAK Signaling

por Rajesh, Christabelle, Sagar, Satish, Rathinavel, Ashok Kumar, Chemparathy, Divya Thomas, Peng, Xianlu Laura, Yeh, Jen Jen, Hollingsworth, Michael A., Radhakrishnan, Prakash
Publicado 2022

Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia

por Shukla, Surendra K, Gebregiworgis, Teklab, Purohit, Vinee, Chaika, Nina V, Gunda, Venugopal, Radhakrishnan, Prakash, Mehla, Kamiya, Pipinos, Iraklis I, Powers, Robert, Yu, Fang, Singh, Pankaj K
Publicado 2014

Correction: Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia

por Shukla, Surendra K, Gebregiworgis, Teklab, Purohit, Vinee, Chaika, Nina V, Gunda, Venugopal, Radhakrishnan, Prakash, Mehla, Kamiya, Pipinos, Iraklis I, Powers, Robert, Yu, Fang, Singh, Pankaj K
Publicado 2014

Insect cell expression and purification of recombinant SARS‐COV‐2 spike proteins that demonstrate ACE2 binding

por Struble, Lucas R., Smith, Audrey L., Lutz, William E., Grubbs, Gabrielle, Sagar, Satish, Bayles, Kenneth W., Radhakrishnan, Prakash, Khurana, Surender, El‐Gamal, Dalia, Borgstahl, Gloria E. O.
Publicado 2022

Inhibition of the Receptor for Advanced Glycation End Products Enhances the Cytotoxic Effect of Gemcitabine in Murine Pancreatic Tumors

por Swami, Priyanka, O’Connell, Kelly A., Thiyagarajan, Swetha, Crawford, Ayrianne, Patil, Prathamesh, Radhakrishnan, Prakash, Shin, Simon, Caffrey, Thomas C., Grunkemeyer, James, Neville, Tammi, Vetter, Stefan W., Hollingsworth, Michael A., Leclerc, Estelle
Publicado 2021

Bromelain Inhibits SARS-CoV-2 Infection in VeroE6 Cells

por Sagar, Satish, Rathinavel, Ashok Kumar, Lutz, William E., Struble, Lucas R., Khurana, Surender, Schnaubelt, Andy T, Mishra, Nitish Kumar, Guda, Chittibabu, Broadhurst, Mara J., Reid, St. Patrick M., Bayles, Kenneth W., Borgstahl, Gloria E. O., Radhakrishnan, Prakash
Publicado 2020

Bromelain inhibits SARS‐CoV‐2 infection via targeting ACE‐2, TMPRSS2, and spike protein

por Sagar, Satish, Rathinavel, Ashok Kumar, Lutz, William E., Struble, Lucas R., Khurana, Surender, Schnaubelt, Andy T., Mishra, Nitish Kumar, Guda, Chittibabu, Palermo, Nicholas Y., Broadhurst, Mara J., Hoffmann, Tobias, Bayles, Kenneth W., Reid, St. Patrick M., Borgstahl, Gloria E. O., Radhakrishnan, Prakash
Publicado 2021

ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody

por Sharma, Sai Kiran, Mack, Kyeara N., Piersigilli, Alessandra, Pourat, Jacob, Edwards, Kimberly J., Keinänen, Outi, Jiao, Maria S., Zhao, Huiyong, White, Brandy, Brooks, Cory L., de Stanchina, Elisa, Madiyalakan, Madi R., Hollingsworth, Michael A., Radhakrishnan, Prakash, Lewis, Jason S., Zeglis, Brian M.
Publicado 2022

Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis

por Pandey, Poomy, Rachagani, Satyanarayana, Das, Srustidhar, Seshacharyulu, Parthasarathy, Sheinin, Yuri, Naslavsky, Naava, Pan, Zenggang, Smith, Brittney L., Peters, Haley L., Radhakrishnan, Prakash, McKenna, Nicole R., Giridharan, Sai Srinivas Panapakkam, Haridas, Dhanya, Kaur, Sukhwinder, Hollingsworth, Michael A., MacDonald, Richard G., Meza, Jane L., Caplan, Steve, Batra, Surinder K., Solheim, Joyce C.
Publicado 2014

Small-molecule IKKβ activation modulator (IKAM) targets MAP3K1 and inhibits pancreatic tumor growth

por Napoleon, John Victor, Sagar, Satish, Kubica, Sydney P., Boghean, Lidia, Kour, Smit, King, Hannah M., Sonawane, Yogesh A., Crawford, Ayrianne J., Gautam, Nagsen, Kizhake, Smitha, Bialk, Pawel A., Kmiec, Eric, Mallareddy, Jayapal Reddy, Patil, Prathamesh P., Rana, Sandeep, Singh, Sarbjit, Prahlad, Janani, Grandgenett, Paul M., Borgstahl, Gloria E. O., Ghosal, Gargi, Alnouti, Yazen, Hollingsworth, Michael A., Radhakrishnan, Prakash, Natarajan, Amarnath
Publicado 2022